Researchers are excited about this new drug, a novel dual agonist showing significant outcomes in early trials for weight loss . It functions by modulating two pathways : GLP-1 and GIP, which , when https://laylaskxh660144.actoblog.com/41652462/the-new-possibility-for-body-management